Govt Job for M.Pharm, B.Pharm as Quality Manager at IGIMS – Salary Rs 39,000/- pm

IGIMS was established on 19th November 1983, as an autonomous organisation on the pattern of All India Institute of Medical Sciences, New Delhi. The objective was to provide super specialty medical facilities in Bihar.

On 27th January 1983 Cabinet approved the completion of this massive project in 4 phases within a span of six (6) years. According to the decision of State Government, 130.20 Acres of land was transferred to IGIMS.

Walk-In-Interview for the post of Quality Manager on contractual basis under research project “To Establish Clinical Trial Networks for hospital-based trial in Ophthalmology”.

Post :Quality Manager (01-UR)

Qualification : B.Pharma/M.Pharma preferably with management certified course
Desirable :- Experience in drug trial

Salary : 39,000/month
Age limit : 35 years
Remarks : Relaxation of age as per rule prescribed.

Candidates having requisite qualification & experience with a copy of complete BIO-DATA with their original papers and its photocopy with two passport size photographs may come for walk-in interview on date and time mentioned below.

No TA/DA is allowed for appearing in the interview. Director, IGIMS, Patna reserves the right to cancel the recruitment process at any stage without assigning any reason.

A Walk-in interview of eligible Indian Citizen for appointment of above post has been fixed on 10-07-2021 at 10:30 A.M.in the office Chamber of the HOD, RIO, IGIMS, Patna

Related Posts

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise